The patient/industry trade-off in medical artificial intelligence

2026-01-05

AI and Ethics

AI Summary

This study addresses the frequent impediment in clinical translation of medical AI, stemming from misaligned incentives between patient benefit and commercial interests. The authors systematically analyze value conflicts within academia–industry–clinical collaborations and propose a sustainable cooperation framework centered on patient benefit. Key components include enhancing model interpretability and transparency, adopting clinically relevant evaluation metrics, integrating clinician and patient input into the design process, and prioritizing partnerships with industry stakeholders committed to patient-centered outcomes. By aligning stakeholder incentives around tangible clinical value, this framework offers a clear pathway and practical guidance to accelerate the responsible deployment of AI technologies that genuinely improve patient care.

Technology Category

• Philosophy and Ethics of AI: Safety, Robustness & Trustworthiness
• Humans and AI: Learning Human Values and Preferences
• Machine Learning: Ethics, Bias, and Fairness

Application Category

• User Modeling, Personalization and Recommendation: Accountability, Transparency, and Ethics for personalization
• Responsible Web: Machine-in-the-loop, human agency and autonomy
• Economics, Online Markets and Human Computation: Fairness and ethical considerations in crowd work and in human-in-the-loop AI systems

Abstract

Artificial intelligence (AI) in healthcare has led to many promising developments; however, increasingly, AI research is funded by the private sector leading to potential trade-offs between benefits to patients and benefits to industry. Health AI practitioners should prioritize successful adaptation into clinical practice in order to provide meaningful benefits to patients, but translation usually requires collaboration with industry. We discuss three features of AI studies that hamper the integration of AI into clinical practice from the perspective of researchers and clinicians. These include lack of clinically relevant metrics, lack of clinical trials and longitudinal studies to validate results, and lack of patient and physician involvement in the development process. For partnerships between industry and health research to be sustainable, a balance must be established between patient and industry benefit. We propose three approaches for addressing this gap: improved transparency and explainability of AI models, fostering relationships with industry partners that have a reputation for centering patient benefit in their practices, and prioritization of overall healthcare benefits. With these priorities, we can sooner realize meaningful AI technologies used by clinicians where mutually beneficial impacts for patients, healthcare providers, and industry can be realized.

Problem

• medical artificial intelligence
• patient-industry trade-off
• clinical integration
• healthcare AI
• industry funding

Innovation

• clinical relevance
• explainable AI
• patient-centered design
• healthcare AI translation
• industry-academia collaboration